Home Health Costs Topics

Health Costs

New and noteworthy

Promotional Image for the KFF video Health Care Affordability at the Macro Level

Health Care Costs Keep Rising … Why and Who Pays?

The U.S. spends more on health care than other large, wealthy countries. Concerns about rising costs aren’t new, yet somehow we keep paying the bill. In this video, KFF’s Larry Levitt explains how we got here, who bears the consequences and why reining in spending systematically may be central to the next big health care debate. KFF’s Larry Levitt, Executive Vice President for Health Policy, explains how we got here, who bears the consequences and why reining in spending systematically may be central to the next big health care debate.

The MIDTERMS

KFF Health Tracking Poll: MAHA and the Midterms

Chemical food additive and pesticide concerns associated with the Make America Health Again (MAHA) movement are shared broadly across the public. But when it comes to voters, health care costs are a higher priority and bigger motivator, even among MAHA supporters, a new KFF Health Tracking Poll finds. When asked to identify their most important health priority for government to address, far more MAHA-supporting voters identify lowering the cost of health care (42%) than other issues more closely associated with the movement.

Health System Tracker

Among adults 18 - 64 with private insurance, mental health and substance use treatment accounted for 10% of all overnight stays at hospitals or other medical facilities in 2023.

Cost and Utilization of Inpatient Mental Health and Substance Use Treatment This analysis describes the most common diagnoses for inpatient treatment and total associated costs.

What Are the Recent Trends in Employer-Based Health Coverage? Employer-sponsored health insurance is the largest source of health coverage for people under 65, but its reach is uneven.

How Does U.S. Life Expectancy Compare to Other Countries? The life expectancy gap between the U.S. and peer countries decreased from 4.1 years in 2023 to 3.7 years in 2024 as U.S. mortality dropped.

How Does Health Spending in the U.S. Compare to Other Countries? While the U.S. still spends the most in total dollars, eight OECD nations had a higher percentage increase in per-person health spending in 2024.

Latest News

More KFF Health News

Stay informed.

Get KFF's latest on Health Costs

Stay informed.

Get KFF's latest on Health Costs

View the Latest: Health Costs

Filter

List Grid

1,151 - 1,160 of 1,597 Results

  • The Role of Independent Commissions in Controlling Costs and Enhancing Value: International Lessons

    Event Date:
    Event

    The Alliance for Health Reform and the Commonwealth Fund co-sponsored this briefing to examine the quasi-governmental authorities that Germany, the Netherlands and France have established to control health care costs, oversee quality, and regulate insurance and provider payment. How and why have these quasi-governmental authorities come into being? What is their scope of power, and the mechanism they provide for bringing stakeholders together in health care decision making? What are the respective roles of government…

  • Health Care Reform and the CLASS Act

    Issue Brief

    This issue brief examines the Community Living Assistance Services and Supports (CLASS) program, a component of the health reform law that establishes a national, voluntary insurance program for purchasing community living services and supports that is designed to expand options for people who become functionally disabled and require long-term help. This brief describes the major components of the CLASS program including its financing, eligibility criteria, benefit design and interaction with Medicaid. Issue Brief (.pdf)

  • Federal Policies Affecting The Cost and Availability of New Pharmaceuticals

    Report

    This report by Michael Gluck of the Georgetown University Institute for Health Care Research and Policy examines several ways in which the federal government influences the availability and cost of prescription drugs, including 1) intellectual property protection the laws and policies which regulate and influence patents and generic competition (include the Hatch-Waxman Act), 2) federal support for drug research and development, 3) federal tax subsidies through various tax credits available to pharmaceutical firms, and 4)…

  • The Sad History of Cost Containment as Told in One Chart

    Other Post

    As the nation once again faces double digit increases in health care costs, the seemingly unanswerable question of how to control the problem has suddenly returned to the nation's radar screen. This analysis by the Kaiser Family Foundation, published in the January 23, 2002 online version of the journal Health Affairs (under Web Exclusives) traces the effectiveness of government and private sector attempts to reign in health care costs over the past three decades and…

  • The Role of National Firms in Medicare+Choice

    Report

    This report addresses national managed care firms participation in M+C and the factors influencing their decision processes about M+C products. Based on interviews with executives and senior staff of national managed care firms, this report examines how eight national firms strategically position their M+C product, including the process that firms use when making decisions and the key factors they say most influence their decisions related to participation. Report

  • The Development of Direct-to-Consumer Prescription Drug Advertising Regulation

    Other Post

    This article, which appears in the Food and Drug Law Journal, vol. 57, no. 3, 2002, pp. 423-444 was based on a report written by F.B. Palumbo and C.D. Mullins at the University of Maryland School of Pharmacy Center on Drugs and Public Policy and funded by the Kaiser Family Foundation. The article provides an historical overview and current U.S. Food and Drug Administration regulation of advertising prescription drugs directly to consumers. The article also…

  • Medicare Cost-Sharing: Implications for Beneficiaries

    Event Date:
    Event

    Tricia Neuman, Vice President and Director of the Medicare Policy Project, testified on behalf of herself and Thomas Rice, Ph.D., of UCLA's School of Public Health, before the House Ways and Means Subcommittee on Health on cost-sharing requirements under Medicare and supplemental Medigap policies. The statement reviews Medicare beneficiaries' current cost-sharing responsibilities, the evidence on the impact of out-of-pocket costs on health-care utilization, and the implications for proposals that would modify Medicare's cost-sharing structure.

  • HIV Capitation Risk Adjustment:  Conference Report

    Report

    HIV Capitation Risk Adjustment: Conference Report This report provides an overview of conference proceedings which focused on developing managed care reimbursement strategies that will ensure quality care for people living with HIV and fair compensation for those providing care. Report: HIV Capitation Risk Adjustment: Conference Report

  • Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001Data Update

    Report

    Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001 Data Update This data update provides estimates of supplemental insurance and prescription drug coverage rates and trends between 1996 and 2001, which will help to provide important context for assessing future changes in supplemental insurance and drug coverage rates after provisions of the Medicare drug benefit take effect. Report (.pdf)